Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for Lymphoma

NCT01987505

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Hospital De Txagorritxu; Servicio de Hematologia Vitoria-Gasteiz, Alava, Spain
  • Hospital General de Elda; Servicio de Hematologia Elda, Alicante, Spain
  • Hospital Son Llatzer; Servicio de Hematologia Palma de Mallorca, Balearic Islands, Spain
  • Hospital de Granollers, Servicio de Hematología Granollers, Barcelona, Spain
View all 39 locations
View Trial Details
Completed

A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial

NCT00737529

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Tower Cancer Research Foundation Los Angeles, California, United States
View all 70 locations
View Trial Details
Completed

A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies

NCT00923520

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +43 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • Hershey Medical Center Hershey, Pennsylvania, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma

NCT01200758

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Gosford Hospital; Cancer Care Services Gosford, New South Wales, Australia
  • Wollongong Hospital; Cancer Services Wollongong, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Herston, Queensland, Australia
  • Gold Coast Hospital; Haematology Department Southport, Queensland, Australia
View all 152 locations
View Trial Details

Related conditions